{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:55:53Z","timestamp":1784170553286,"version":"3.55.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Oral contraceptive pills are among the most popular contraceptives worldwide, including among adolescents, and are available over the counter in over 100 countries. However, when a prescription is required, oral contraceptives may be difficult to obtain, particularly for adolescents. Recent approvals of over-the-counter progestin-only pills in the United Kingdom and United States have brought widespread attention to this topic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Progestin-only pills, including the norgestrel pill recently approved for over-the-counter use in the United States, are highly effective and may be used safely without a prescription or medical monitoring, including by adolescents. These pills are associated with relatively high user satisfaction. Although over-the-counter availability may improve contraceptive access overall, issues related to insurance coverage and out-of-pocket cost may continue to pose practical barriers to access for many individuals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Over-the-counter oral contraceptives are an appropriate and important contraceptive option for many adolescents. Over-the-counter availability has the potential to increase access to safe and effective contraception in the United States, United Kingdom, and other countries where a prescription is currently required. Future research on use patterns among adolescents is needed, as are advocacy efforts and policies to ensure access and affordability.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001346","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T07:03:54Z","timestamp":1713942234000},"page":"382-388","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Over-the-counter access to hormonal contraception: a global perspective"],"prefix":"10.1097","volume":"36","author":[{"given":"Alana K.","family":"Otto","sequence":"first","affiliation":[{"name":"Division of Adolescent Medicine, Department of Pediatrics, University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Klein","sequence":"additional","affiliation":[{"name":"Departments of Family Medicine and Pediatrics, Uniformed Services University, Bethesda, Maryland"},{"name":"Department of Family Medicine, David Grant Medical Center, Travis Air Force Base, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Lau","sequence":"additional","affiliation":[{"name":"Division of Developmental-Behavioral Pediatrics, Department of Pediatrics, University of Texas Southwestern Medical Center, Children's Medical Center Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherie P.","family":"Dhar","sequence":"additional","affiliation":[{"name":"The Potocsnak Family Division of Adolescent and Young Adult Medicine, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris Y.","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Adolescent & Young Adult Medicine, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2012.11.021","article-title":"Prescription requirements and over-the-counter access to oral contraceptives: a global review","volume":"88","author":"Grindlay","year":"2013","journal-title":"Contraception"},{"issue":"(Suppl 2)","key":"R7-20250730","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3109\/13625187.2010.513071","article-title":"History of oral contraception","volume":"15","author":"Dhont","year":"2010","journal-title":"Eur J Contracept Reprod Healthcare"},{"key":"R8-20250730","first-page":"2","article-title":"Thromboembolism and the pill \u2013 new data","volume":"2","year":"1968","journal-title":"IPPF Med Bull"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0968-8080(94)90077-9","article-title":"Over-the-counter distribution of oral contraceptives","volume":"2","author":"Allina","year":"1994","journal-title":"Reprod Health Matters"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2307\/2947920","article-title":"Nonclinical distribution of the pill in the developing world","volume":"6","author":"Rosenfield","year":"1980","journal-title":"Int Fam Plan Perspect"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjsrh-2020-200906","article-title":"Oral contraception over the counter at last: a momentous occasion","volume":"48","author":"Glasier","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"109978","DOI":"10.1016\/j.contraception.2023.109978","article-title":"A commentary on progestin-only pills and the \u201cthree-hour window\u201d guidelines: timing of ingestion and mechanisms of action","volume":"122","author":"Wollum","year":"2023","journal-title":"Contraception"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1783\/147118908786000451","article-title":"Ovulation incidence with oral contraceptives: a literature review","volume":"34","author":"Milsom","year":"2008","journal-title":"J Fam Plann Reprod Healthcare"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2022.03.022","article-title":"Mechanism of action of norgestrel 0.075\u200amg a progestogen-only pill. I. Effect on ovarian activity","volume":"112","author":"Glasier","year":"2022","journal-title":"Contraception"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.contraception.2022.03.016","article-title":"Mechanism of action of a 0.075\u200amg norgestrel progestogen-only pill. 2. Effect on cervical mucus and theoretical risk of conception","volume":"112","author":"Han","year":"2022","journal-title":"Contraception"},{"issue":"(11)","key":"R26-20250730","first-page":"CD007541","article-title":"Progestin-only pills for contraception","author":"Grimes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"109925","DOI":"10.1016\/j.contraception.2022.109925","article-title":"Effectiveness and efficacy rates of progestin-only pills: a comprehensive literature review","volume":"119","author":"Zuniga","year":"2023","journal-title":"Contraception"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2021.08.016","article-title":"A review of the effectiveness of a progestogen-only pill containing norgestrel 75\u200a\u03bcg\/day","volume":"105","author":"Glasier","year":"2022","journal-title":"Contraception"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.09.002","article-title":"The effect of deliberate nonadherence to a norgestrel progestin-only pill: a randomized, crossover study","volume":"117","author":"Glasier","year":"2023","journal-title":"Contraception"},{"key":"R31-20250730","first-page":"1","article-title":"U. S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jadohealth.2021.04.032","article-title":"Adolescents\u2019 and young adults\u2019 ability to self-screen for contraindications to hormonal contraception and the role of chronic illness","volume":"69","author":"Wilkinson","year":"2021","journal-title":"J Adolesc Health"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1363\/psrh.12214","article-title":"Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States","volume":"55","author":"Grindlay","year":"2023","journal-title":"Perspect Sex Reprod Health"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.contraception.2005.12.001","article-title":"Agreement between women's and providers\u2019 assessment of hormonal contraceptive risk factors","volume":"73","author":"Shotorbani","year":"2006","journal-title":"Contraception"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmjsrh-2022-201637","article-title":"Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey","volume":"49","author":"Grindlay","year":"2023","journal-title":"BMJ Sex Reprod Health"},{"key":"R38-20250730","first-page":"904","article-title":"Interest in continued use after participation in a study of over-the-counter progestin-only pills in the United States","volume":"3","author":"Grindlay","year":"2022","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jwh.2015.5312","article-title":"Prescription birth control access among U.S. women at risk of unintended pregnancy","volume":"25","author":"Grindlay","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"109950","DOI":"10.1016\/j.contraception.2023.109950","article-title":"Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: an online cross-sectional survey","volume":"120","author":"Key","year":"2023","journal-title":"Contraception"},{"issue":"(Pt 1)","key":"R42-20250730","first-page":"384","article-title":"ACOG Committee Opinion No. 586: health disparities in rural women","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jadohealth.2009.09.003","article-title":"Who gets confidential care? Disparities in a national sample of adolescents","volume":"46","author":"Edman","year":"2010","journal-title":"J Adolesc Health"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2022.10.006","article-title":"Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the US","volume":"117","author":"Guillard","year":"2023","journal-title":"Contraception"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.whi.2020.01.003","article-title":"Modeling the impacts of price of an over-the-counter progestin-only pill on use and unintended pregnancy among U.S. women","volume":"30","author":"Wollum","year":"2020","journal-title":"Womens Health Issues"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.contraception.2015.01.010","article-title":"Potential public sector cost-savings from over-the-counter access to oral contraceptives","volume":"91","author":"Foster","year":"2015","journal-title":"Contraception"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.whi.2017.11.006","article-title":"Interest in over-the-counter access to a progestin-only pill among women in the United States","volume":"28","author":"Grindlay","year":"2018","journal-title":"Womens Health Issues"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.contraception.2012.03.003","article-title":"Reproductive health preventive screening among clinic vs. over-the-counter oral contraceptive users","volume":"86","author":"Hopkins","year":"2012","journal-title":"Contraception"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ogc.2015.07.002","article-title":"Over-the-counter access to oral contraceptives","volume":"42","author":"Grossman","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0020-7292(01)00375-7","article-title":"Over-the-counter use of oral contraceptives in Kuwait","volume":"73","author":"Shah","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/AOG.0b013e31820afc46","article-title":"Continuation of prescribed compared with over-the-counter oral contraceptives","volume":"117","author":"Potter","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(04)00086-2","article-title":"Confidential healthcare for adolescents: position paper of the Society for Adolescent Medicine","volume":"35","author":"Ford","year":"2004","journal-title":"J Adolesc Health"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"e1244","DOI":"10.1542\/peds.2014-2299","article-title":"Contraception for adolescents","volume":"134","author":"Braverman","year":"2014","journal-title":"Pediatrics"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/AOG.0000000000003770","article-title":"ACOG Committee Opinion: confidentiality in adolescent healthcare","volume":"135","year":"2020","journal-title":"Obstet Gynecol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:07:17Z","timestamp":1753898837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001346","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]}}}